Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antibody drug conjugates: the future of chemotherapy?
Borcoman E, Le Tourneau C. Borcoman E, et al. Among authors: le tourneau c. Curr Opin Oncol. 2016 Sep;28(5):429-36. doi: 10.1097/CCO.0000000000000310. Curr Opin Oncol. 2016. PMID: 27366963 Review.
Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial.
Frenel JS, Le Tourneau C, O'Neil B, Ott PA, Piha-Paul SA, Gomez-Roca C, van Brummelen EMJ, Rugo HS, Thomas S, Saraf S, Rangwala R, Varga A. Frenel JS, et al. Among authors: le tourneau c. J Clin Oncol. 2017 Dec 20;35(36):4035-4041. doi: 10.1200/JCO.2017.74.5471. Epub 2017 Nov 2. J Clin Oncol. 2017. PMID: 29095678 Clinical Trial.
Pembrolizumab for the Treatment of Advanced Salivary Gland Carcinoma: Findings of the Phase 1b KEYNOTE-028 Study.
Cohen RB, Delord JP, Doi T, Piha-Paul SA, Liu SV, Gilbert J, Algazi AP, Damian S, Hong RL, Le Tourneau C, Day D, Varga A, Elez E, Wallmark J, Saraf S, Thanigaimani P, Cheng J, Keam B. Cohen RB, et al. Among authors: le tourneau c. Am J Clin Oncol. 2018 Nov;41(11):1083-1088. doi: 10.1097/COC.0000000000000429. Am J Clin Oncol. 2018. PMID: 29462123 Free PMC article.
Patterns of Response and Progression to Immunotherapy.
Borcoman E, Nandikolla A, Long G, Goel S, Le Tourneau C. Borcoman E, et al. Among authors: le tourneau c. Am Soc Clin Oncol Educ Book. 2018 May 23;38:169-178. doi: 10.1200/EDBK_200643. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231380 Free article. Review.
Novel patterns of response under immunotherapy.
Borcoman E, Kanjanapan Y, Champiat S, Kato S, Servois V, Kurzrock R, Goel S, Bedard P, Le Tourneau C. Borcoman E, et al. Among authors: le tourneau c. Ann Oncol. 2019 Mar 1;30(3):385-396. doi: 10.1093/annonc/mdz003. Ann Oncol. 2019. PMID: 30657859 Free article.
Molecular profiling in precision medicine oncology.
Le Tourneau C, Borcoman E, Kamal M. Le Tourneau C, et al. Nat Med. 2019 May;25(5):711-712. doi: 10.1038/s41591-019-0442-2. Nat Med. 2019. PMID: 31036881 No abstract available.
Hyperprogression under Immunotherapy.
Frelaut M, Le Tourneau C, Borcoman E. Frelaut M, et al. Among authors: le tourneau c. Int J Mol Sci. 2019 May 30;20(11):2674. doi: 10.3390/ijms20112674. Int J Mol Sci. 2019. PMID: 31151303 Free PMC article. Review.
284 results